treatment News

SOUTH BEND, Ind.– Indiana University School of Medicine researchers at the school’s South Bend regional campus, in collaboration with colleagues at the University of Notre Dame, have identified a new therapeutic target for pulmonary hypertension, a type of high blood pressure that affects the blood vessels in the lungs. Their...
A new cognitive test for detecting Alzheimer’s disease is quicker and more accurate than many current tests, and could help diagnose early dementia, concludes a study published on bmj.com today. An estimated 24 million people throughout the world have dementia and the number affected will double every 20 years. Early...
Vienna, Austria – A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the inhibition of a specific signaling pathway showed clear success in the treatment of granulomas in the skin. This...
BALTIMORE, Maryland — Researchers at Kennedy Krieger Institute have made significant strides in improving the lives of patients with Tourette syndrome. Their recent publication highlights how behavioral therapies—an approach that teaches patients how to manage certain tics using behavioral strategies—are proving to be the most effective treatment. Tourette syndrome (TS),...
WALTHAM, Mass. — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch and uptake of new anti-amyloid monoclonal antibodies, most notably Elan/Wyeth’s bapineuzumab and Eli Lilly’s solanezumab, will be the main driver of robust 11 percent annual growth from...
Trondheim, Norway – A lot of research has been done over many decades on diseases that are widespread in large parts of the population, such as cancer and heart disease. As a result, treatment methods have improved enormously thanks to long-term research efforts on diseases that affect many people. However,...
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body’s immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system. John M. Maris, M.D., chief of Oncology at The Children’s Hospital of Philadelphia, co-authored the phase...
PHILADELPHIA — A multicenter research team has announced encouraging results for an experimental therapy using elements of the body’s immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system. John M. Maris, M.D., chief of Oncology at The Children’s Hospital of Philadelphia, co-authored...